Created in July 2006, BioWin is the reference player in the field of health biotechnology and medical technologies in Wallonia (a region located South Brussels, in Belgium). The cluster federates all the Walloon stakeholders (170 companies, several research centers and 5 universities) involved in innovative R&D projects and/or trainings for the development of new products and services. BioWin has defined 4 strategic priorities: innovative R&D projects, building the skills that industry players need to succeed, international footprint of the cluster and its members, and the creation of technological platforms. For more information about the cluster: www.biowin.org. For more information about our members news on our blog: http://win-health.org.
WAL-DX is a network of about more than 25 BioWin members (mainly innovative high potential SMEs + universities) who are active in the area of in Vitro diagnostics. They operate in a range of niches, from academic research to development, as well as from the production of diagnostic tests and equipment to support technologies.
EXPERTISE, RESOURCES AND INNOVATION CAPACITIES IN IVD
- Diagnostic tools development (microfluidics, capillary electrophoresis, ELISA, PRC, oligochromatography, next-generation sequencing, nanoparticles, etc.)
- Signal analysis
- Design & production
- Data management
- Science, Technology and Education
- Biomarkers identification & industrialization
Frédéric Druck, Deputy Managing Director
Head of Communication, International Relations and Training
Tel.: +32 (0) 71 376 386
Point Centre – Avenue Georges Lemaître, 19
6041 Gosselies - Belgium